Regulatory Oversight or Lack of Foresight? Implications for Product Recall Policies and Procedures
AbstractThe regulatory effectiveness, the impact on industry and consumers of product withdrawal and the associated wider issues relating to crisis management represent an under-researched area. The authors describe the mid-2003 government-ordered withdrawal of almost 2,000 complementary and alternative medicines, across multiple brand names, in Australia and New Zealand. The report is based on an examination of the media coverage of the event and on interviews with key informants in manufacturing and retailing and the regulatory system. This massive, multi-brand recall provides an opportunity to examine the effectiveness and efficiency of the management of a cross-border withdrawal from regulatory and consumer policy perspectives and makes recommendations for the management of future recall events. Copyright Springer 2005
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
Bibliographic InfoArticle provided by Springer in its journal Journal of Consumer Policy.
Volume (Year): 28 (2005)
Issue (Month): 4 (December)
Contact details of provider:
Web page: http://www.springerlink.com/link.asp?id=100283
You can help add them by filling out this form.
reading list or among the top items on IDEAS.Access and download statisticsgeneral information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Guenther Eichhorn) or (Christopher F. Baum).
If references are entirely missing, you can add them using this form.